Clinical Trials | Pulmonary Fibrosis Foundation
Global Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Highlights - 2022
.png "REMAP-ILD: The future of clinical trials in pulmonary fibrosis – Action for Pulmonary Fibrosis")
REMAP-ILD: The future of clinical trials in pulmonary fibrosis – Action for Pulmonary Fibrosis
Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns and current practices - Mayo Clinic
Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years | European Respiratory Society
The therapy of idiopathic pulmonary fibrosis: what is next? | European Respiratory Society
![Top 10 IPF Clinical Trials [2023 Studies] | Power](https://pwr-og-img.withpower.com/IPF%20research%20studies%20recruiting%20patients%20in%202023%20need%20your%20help.%20Receive%20premium%20care%20&%20cutting%20edge%20treatments%20by%20enrolling%20in%20idiopathic%20pulmonary%20fibrosis%20clinical%20trials%20today..png?md=1 "Top 10 IPF Clinical Trials [2023 Studies] | Power")
Top 10 IPF Clinical Trials [2023 Studies] | Power
A summary of end points that may be used in IPF-PH clinical trials.... | Download Scientific Diagram
Ongoing clinical trials in idiopathic pulmonary fibrosis | Download Table
Clinical Trial for Idiopathic Pulmonary Fibrosis - Responsum Health
Pulmonary Fibrosis: Diagnosis and Treatment | Consultant360
Phase IV IPF Clinical Trials | ILD Collaborative
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development | SpringerLink
Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme | Respiratory Research | Full Text
Live Well Breathe Better- Pulmonary Fibrosis - Understanding Pulmonary Fibrosis Clinical Trials - YouTube
Idiopathic Pulmonary Fibrosis Disease - Global Clinical Trials Review, H2, 2020
Frontiers | Challenges for Clinical Drug Development in Pulmonary Fibrosis
Selected recent clinical trials in idiopathic pulmonary fibrosis | Download Table
Targeting fibrosis: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
Enrollment now complete for Phase 3 trial of pamrevlumab in IPF | Results from FibroGen study ZEPHYRUS-2 expected in mid-2024 | Pulmonary Fibrosis News
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis - The Lancet Respiratory Medicine
Clinical Trials | Pulmonary Fibrosis Foundation
